276 related articles for article (PubMed ID: 37887406)
1. Recent Advances in the Application of Cucurbitacins as Anticancer Agents.
Zieniuk B; Pawełkowicz M
Metabolites; 2023 Oct; 13(10):. PubMed ID: 37887406
[TBL] [Abstract][Full Text] [Related]
2. Potential of cucurbitacin as an anticancer drug.
Li Y; Li Y; Yao Y; Li H; Gao C; Sun C; Zhuang J
Biomed Pharmacother; 2023 Dec; 168():115707. PubMed ID: 37862969
[TBL] [Abstract][Full Text] [Related]
3. Biological activities and potential molecular targets of cucurbitacins: a focus on cancer.
Chen X; Bao J; Guo J; Ding Q; Lu J; Huang M; Wang Y
Anticancer Drugs; 2012 Sep; 23(8):777-87. PubMed ID: 22561419
[TBL] [Abstract][Full Text] [Related]
4. Cucurbitacins - a promising target for cancer therapy.
Alghasham AA
Int J Health Sci (Qassim); 2013 Jan; 7(1):77-89. PubMed ID: 23559908
[TBL] [Abstract][Full Text] [Related]
5. Cucurbitacins: A Systematic Review of the Phytochemistry and Anticancer Activity.
Cai Y; Fang X; He C; Li P; Xiao F; Wang Y; Chen M
Am J Chin Med; 2015; 43(7):1331-50. PubMed ID: 26503558
[TBL] [Abstract][Full Text] [Related]
6. Cucurbitacins as potential anticancer agents: new insights on molecular mechanisms.
Varela C; Melim C; Neves BG; Sharifi-Rad J; Calina D; Mamurova A; Cabral C
J Transl Med; 2022 Dec; 20(1):630. PubMed ID: 36585670
[TBL] [Abstract][Full Text] [Related]
7. Apoptotic and antimetastatic effect of cucurbitacins in cancer: recent trends and advancement.
Kumar A; Sharma B; Sharma U; Parashar G; Parashar NC; Rani I; Ramniwas S; Kaur S; Haque S; Tuli HS
Naunyn Schmiedebergs Arch Pharmacol; 2023 Sep; 396(9):1867-1878. PubMed ID: 37010571
[TBL] [Abstract][Full Text] [Related]
8. [Preparation of cucurbitacin compounds in
Sun J; Sun J; Li H; Yan X; Li D; Lu F
Se Pu; 2022 Apr; 40(4):364-371. PubMed ID: 35362684
[TBL] [Abstract][Full Text] [Related]
9. Cucurbitacin: ancient compound shedding new light on cancer treatment.
Lee DH; Iwanski GB; Thoennissen NH
ScientificWorldJournal; 2010 Mar; 10():413-8. PubMed ID: 20209387
[TBL] [Abstract][Full Text] [Related]
10. Cucurbitacins and the Immune System: Update in Research on Anti- inflammatory, Antioxidant, and Immunomodulatory Mechanisms.
Silvestre GFG; de Lucena RP; da Silva Alves H
Curr Med Chem; 2022; 29(21):3774-3789. PubMed ID: 34994307
[TBL] [Abstract][Full Text] [Related]
11. Cucurbitacins as inducers of cell death and a rich source of potential anticancer compounds.
Ríos JL; Andújar I; Escandell JM; Giner RM; Recio MC
Curr Pharm Des; 2012; 18(12):1663-76. PubMed ID: 22443631
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics and Biological Activity of Cucurbitacins.
Delgado-Tiburcio EE; Cadena-Iñiguez J; Santiago-Osorio E; Ruiz-Posadas LDM; Castillo-Juárez I; Aguiñiga-Sánchez I; Soto-Hernández M
Pharmaceuticals (Basel); 2022 Oct; 15(11):. PubMed ID: 36355498
[TBL] [Abstract][Full Text] [Related]
13. Cucurbitacins as Anticancer Agents: A Patent Review.
Hussain H; Green IR; Saleem M; Khattak KF; Irshad M; Ali M
Recent Pat Anticancer Drug Discov; 2019; 14(2):133-143. PubMed ID: 30451116
[TBL] [Abstract][Full Text] [Related]
14. Identification of seven undescribed cucurbitacins in Cucumis sativus (cucumber) and their cytotoxic activity.
Qing Z; Shi Y; Han L; Li P; Zha Z; Liu C; Liu X; Huang P; Liu Y; Tang Q; Zeng K; Zeng J; Zhou Y
Phytochemistry; 2022 May; 197():113123. PubMed ID: 35182783
[TBL] [Abstract][Full Text] [Related]
15. Cucurbitacin E, An Experimental Lead Triterpenoid with Anticancer, Immunomodulatory and Novel Effects Against Degenerative Diseases. A Mini-Review.
Attard E; Martinoli MG
Curr Top Med Chem; 2015; 15(17):1708-13. PubMed ID: 25915611
[TBL] [Abstract][Full Text] [Related]
16. Cucurbitacins as Potent Chemo-Preventive Agents: Mechanistic Insight and Recent Trends.
Tuli HS; Rath P; Chauhan A; Ranjan A; Ramniwas S; Sak K; Aggarwal D; Kumar M; Dhama K; Lee EHC; Yap KC; Capinpin SM; Kumar AP
Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671442
[TBL] [Abstract][Full Text] [Related]
17. Isolation of anticancer constituents from Cucumis prophetarum var. prophetarum through bioassay-guided fractionation.
Alsayari A; Kopel L; Ahmed MS; Soliman HSM; Annadurai S; Halaweish FT
BMC Complement Altern Med; 2018 Oct; 18(1):274. PubMed ID: 30301463
[TBL] [Abstract][Full Text] [Related]
18. Metabolite Profiling and Quantitation of Cucurbitacins in Cucurbitaceae Plants by Liquid Chromatography coupled to Tandem Mass Spectrometry.
Ul Haq F; Ali A; Khan MN; Shah SMZ; Kandel RC; Aziz N; Adhikari A; Choudhary MI; Ur-Rahman A; El-Seedi HR; Musharraf SG
Sci Rep; 2019 Nov; 9(1):15992. PubMed ID: 31690753
[TBL] [Abstract][Full Text] [Related]
19. Recombinant yeast as a functional tool for understanding bitterness and cucurbitacin biosynthesis in watermelon (Citrullus spp.).
Davidovich-Rikanati R; Shalev L; Baranes N; Meir A; Itkin M; Cohen S; Zimbler K; Portnoy V; Ebizuka Y; Shibuya M; Burger Y; Katzir N; Schaffer AA; Lewinsohn E; Tadmor Y
Yeast; 2015 Jan; 32(1):103-14. PubMed ID: 25308777
[TBL] [Abstract][Full Text] [Related]
20. Activated kRas protects colon cancer cells from cucurbitacin-induced apoptosis: the role of p53 and p21.
Escandell JM; Kaler P; Recio MC; Sasazuki T; Shirasawa S; Augenlicht L; Ríos JL; Klampfer L
Biochem Pharmacol; 2008 Jul; 76(2):198-207. PubMed ID: 18561895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
